News Website

Precision Therapeutic and Preventive Molecular Strategies for Endometriosis-Associated Infertility.

Endometriosis, a chronic estrogen-dependent disorder defined by ectopic endometrial-like tissue growth, causes pelvic pain and infertility in reproductive-age women. Despite its prevalence, the underlying mechanisms driving lesion persistence and reproductive …

Published: Aug. 9, 2025, midnight

Read Full Article

biomarkers endometriosis-associated infertility epigenetics prevention therapeutics

Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections - AInvest

Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections AInvest

Published: Aug. 8, 2025, 7:14 a.m.

Read Full Article

Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer - TipRanks

Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer TipRanks

Published: Aug. 7, 2025, 4:18 p.m.

Read Full Article

Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. - 매일경제

Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. 매일경제

Published: July 28, 2025, 6:56 a.m.

Read Full Article

Universal Quantum Joins Institute To Advance Endometrius Therapeutics - Quantum Zeitgeist

Universal Quantum Joins Institute To Advance Endometrius Therapeutics Quantum Zeitgeist

Published: July 24, 2025, 11:09 a.m.

Read Full Article

Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? - AInvest

Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? AInvest

Published: July 2, 2025, 1:04 p.m.

Read Full Article

Womens Health Therapeutics Market to Reach USD 61.6 Billion by 2032, Driven by Innovation - newstrail.com

Womens Health Therapeutics Market to Reach USD 61.6 Billion by 2032, Driven by Innovation newstrail.com

Published: July 1, 2025, 10:45 a.m.

Read Full Article

Women's Health Therapeutics Market Revenue to Attain USD 64.04 Bn by 2033 - Precedence Research

Women's Health Therapeutics Market Revenue to Attain USD 64.04 Bn by 2033 Precedence Research

Published: June 13, 2025, 1:43 p.m.

Read Full Article

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting - TradingView

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting TradingView

Published: June 2, 2025, 11:30 a.m.

Read Full Article

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi) - The Manila Times

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi) The Manila Times

Published: May 27, 2025, 12:47 p.m.

Read Full Article

Latest Articles

Precision Therapeutic and Preventive Molecular Strategies for Endometriosis-Associated Infertility.

Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections - AInvest

Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer - TipRanks

Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. - 매일경제

Universal Quantum Joins Institute To Advance Endometrius Therapeutics - Quantum Zeitgeist

Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? - AInvest

Womens Health Therapeutics Market to Reach USD 61.6 Billion by 2032, Driven by Innovation - newstrail.com

Women's Health Therapeutics Market Revenue to Attain USD 64.04 Bn by 2033 - Precedence Research

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting - TradingView

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi) - The Manila Times

Subscribe to Our Newsletter